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ABSTRACT
Considering the innovative nature of the approach to human exposome, we present the state 
of the art of studies on exposome, and discuss current challenges and perspectives in this 
area. Several reading and discussion activities were conducted by the Expossoma e Saúde 
do Trabalhador (eXsat – Group Exposome and Worker’s Health), with systematization of 
the literature in the area published between January 2005 and January 2017, available in the 
databases PubMed and Web of Science. This comment brings a thematic analysis to encourage 
the dissemination of the exposome approach for studies in the Public Health area. 
DESCRIPTORS: Environmental Pollutants, adverse effects. Risk Assessment. Epidemiology. 
Toxicology. Environmental Health. Exposure Science.
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INTRODUCTION
The progress in the study of exposure science began with the interest in the environmental 
origins of human diseases, which brought advances relevant to public and occupational 
health1,2. In the first half of the 20th century, scientists and engineers from the health 
area already had instruments to measure the exposure available, which allowed a 
more enhanced building of the exposure-response relations for occupational diseases. 
As described by Rappaport1 (2011), the scientific studies on this subject were developed 
first in mines and factories and aimed at measuring the dust and chemical compounds 
transported by air. Between the 1950s and 1970s, the studies of urban pollutants began, 
including contaminants of water and air. While the first personal sampling techniques 
were carried out in workplaces in the 1960s, in the 1970s, the first American laws 
associated with exposure were created. These laws established the OSHA (Occupational 
Safety and Health Administration) to secure and oblige the compliance of the exposure 
limits in the workplace, and the EPA (Environmental Protection Agency) to assess risks 
and regulate contaminants in water and air. Despite the immeasurable progress that 
the creation of these agencies represented to the exposure science, the creation of these 
two agencies resulted in a separation between the professionals of the exposure area and 
divided the professional training and study design according to the exposure source, 
whether occupational or environmental1. 
Considering this brief history, despite advances, the environmental and occupational 
toxicology began to be treated as independent areas with regard to the direction of projects 
and professional and scientific training. This separation encouraged research involving 
chemicals of regulatory importance primarily, as it discouraged the discovery of other 
sources of exposures that may be responsible for most diseases1. Several researches in 
environmental epidemiology deal with secondary data and concentrate investigations 
in particular exhibitions that evaluate the effects of the contamination of water, air, diet, 
stress, different life styles or types of infection on health outcomes. This information 
reflects the historical way of doing science, as a pie, in which each group of researchers 
deals with a piece. This limited division of the science pie leads to the scientific separation 
and confuses the definition of environmental exposures. 
The modern toxicology investigates a wide range of dangers, both the old ones that 
still require confronting, as the emerging ones3. To reach their goals and advance 
in knowledge, the area has been supporting itself on tools related to genome and 
toxicogenomics. The great complexity of metabolic pathways, considering the exposure 
biology, must be studied when the interactions between genes and environment are 
investigated. During the life cycle, individuals are simultaneously exposed to a wide 
variety of factors. All categories of these exposure factors (general external exposure, 
specific external exposure and internal exposure) can contribute to the establishment 
of chronic diseases; thus, all the risk factors of interest should have been investigated 
collectively, and not individually4. 
To better conduct the studies in this era of complexity of realities and avalanche of 
information, toxicology requires a closer connection with other disciplines, such as 
epidemiology and bioinformatics. We must consider that old dangers remain in the priority 
list to be studied and discussed, such as exposure to lead; however, daily, molecules are 
produced to satisfy the comfort of modern society. These molecules also have a biological 
effect. Between the discovery of a molecule and the study of its toxicity, there is a gap of 
time. In this period, the population may present health outcomes before the toxicity of the 
molecule is proven and its regulation, held. 
The comprehension of the extent of genomic diversity among human beings, the recognition 
of the connection between phenotypes and diseases, and the discovery of environmental 
exposures that are harmful to our health are issues that continue to be faced by science5. 
In this sense, the fragmentation of epidemiological research symbolizes an obstacle in the 
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identification of the main exposures4. The use of inappropriate risk models and the current 
limitation in measurement instruments can collaborate for the main environmental risk 
factors to remain unknown, underestimated or limited, as the exposures that impact on 
health the most may be in synergy with other exposures or biological or behavioral factors6. 
For this reason, studies based on molecular epidemiology are translated into an important 
tool to investigate the health effects in various exposure circumstances in humans. 
Biospecimen banks are of utmost importance to the studies on specific biological markers 
of certain diseases. In the field of toxicogenomics, the enzymes, their coding genes, and 
the metabolism of exogenous agents are used to investigate environmental factors from 
exposure to effect. The identification of the polymorphism of these genes indicates potential 
modifiers of the pathogenesis of environmental diseases3.
Concept and Method of Exposome
In this context, the need of considering different exposures in the same epidemiological 
design led to the emergence of the concept of exposome. This term was coined 
by Wild7 in 2005 and comprises the totality of human exposures throughout 
life, from the conception to the death. Miller and Jones8 ref ined the concept of 
exposome as the cumulative measure of environmental inf luences and associated 
biological responses, including exposures of environment, diet , behavior and 
endogenous processes throughout life. The exposome is concomitantly based on 
three domains. Internal factors are those unique of individuals, such as physiology, age, 
body morphology and individual’s genome; general external factors include socioeconomic 
condition, sociodemographic factors and place of residence; and specific external factors 
include diet, lifestyle, environmental and occupational exposures, among others1,4. 
A coherent view of the environmental exposure acknowledges that the toxic effects are 
mediated by chemicals that alter critical molecules, cells and physiological processes within 
the body. Therefore, we can consider the environment as the internal chemical environment 
of the body and the exposures as the quantities of biologically-active chemicals in this 
internal environment4. In this view, exposures can originate from chemicals (toxicants) 
from the air, the water or the food. However, they include also chemicals produced by 
inflammation, oxidative stress, lipid peroxidation, inflammation, intestinal flora and other 
natural processes4,9,10. This internal chemical environment is dynamic because of changes 
in internal and external sources, aging, infections, lifestyle, stress, psychological factors 
and preexistent diseases10,11. 
Recent listings show that humans are exposed to several chemical stressors throughout life. 
For example, by the US Toxic Substances Control Act, the EPA compiled 84,000 chemicals 
for which there is a risk of exposure. A total of 3,600 toxicants were identified in the Toxic 
Exposome Database and other 13,000 in the Comparative Toxigenomics Database12. Rappaport 
et al.13 related the risk of chronic diseases with the concentration of 1,561 chemicals in the 
blood, diet derivatives, pollutants, drugs or endogenous agents. From these chemicals, only 300 
have been assessed in clinical and epidemiological studies, which indicates the importance of 
expanding the research beyond the endogenous metabolism, including the activity of several 
active chemicals. The study of exposome includes analyses of small molecules, products of 
metabolism (endogenous exposures); non-chemical stressors, such as radiation and climate; 
and exposure to complex mixtures such as air and water pollution. Endogenous factors such 
as oxidative stress, interaction between exogenous agents and metabolism, DNA repair 
mechanisms and mutations must also be considered when studying the human exposome14–16. 
To evaluate several exposures simultaneously can provide a more accurate analysis of the 
impact of the environment on human health6. For that, the exposome characterization can 
follow two strategies: bottom-up and top-down. In the first, chemicals from each external 
source of an individual exposure are selected and measured at each point in time. In the 
second, chemicals and their metabolites are evaluated according to the toxicant profile 
and classes that cause diseases: metals, reactive electrophiles, endocrine disruptors, 
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modulators of immune responses and agents that connect to cell receptors4,10,17,18. 
Considering these strategies, Rappaport1 proposes the application of a top-down approach 
based on biomonitoring with blood sampling. In this case, because exposure sources and 
levels change over time, the exposome can be characterized according to analysis of blood 
samples obtained in critical stages of life. More recently, the research group of the same 
author has proposed this biomonitoring with total saliva collection19. 
To sequence the exposome, data analysis methods of high performance can be used to 
discover relationships between exposure, genome and diseases of interest, especially chronic 
diseases of unknown causes. There is evidence that genetic variants explain a limited fraction 
– 10% to 30% – of the variability of risk of chronic diseases1,4, which indicates the expressive 
role of environmental exposures and of the interaction between environmental and genetic 
factors20. Considering allergic diseases, for example, genetic studies provide insights about 
the mechanisms involved in its occurrence. The same reasoning can be applied in other 
cases, as in type II diabetes or obesity. Various environmental and lifestyle risk factors 
(urbanization, air pollution, occupational exposure, viral infections, smoking, diet, etc.) 
have been associated with the development of asthma and allergic diseases, which shows 
the importance of considering the set of exposures in the etiology of diseases6.
To discuss and evaluate the concept, one must make the distinction between the exposomic 
methodology and the underlying phenomenon to be measured11. The exposome is a compilation 
of non-genetic exposures that influence human health. Its study is conducted by the exposomic 
methodology, which involves simultaneous measurement of a set of biomarkers21, possible by 
the advances occurring in laboratory sciences. Currently, the simultaneous interpretation of 
thousands of individual compounds, such as metabolites, proteins, lipids and transcripts, is a 
reality. High-performance technologies such as omics (metabolomics, proteomics, adutomics, 
transcriptomics, lipidomics, etc.), allied to the evaluation devices of exposure to pollutants, 
and the evaluation questionnaires of past exposure and lifestyle form the measurement 
of the three aforementioned dimensions of the exposome: internal, general external, and 
specific external. The use of these technologies in epidemiological and longitudinal designs 
with powerful processing of large databases can lead to conclusions faster than in studies of 
isolated groups22. Statistical models that enable the integration of information obtained will 
be able to enhance risk assessment studies, to contribute to the disease prevention, and to 
generate accurate and pesonalized diagnoses to the medicine23.
What has been Developed in Studies of Exposome?
Some readers may consider the concept of exposome discouraging, especially because of 
the idea of measuring all exposures to which an individual has been subjected throughout 
life and predicting their impact on health. However, large cohort studies have already been 
conducted in the world considering the principles of the exposome. Such studies have been 
increasing the accuracy of estimated associations between exposures, effects and health 
conditions24. The National Institute of Environmental Health Sciences (NIEHS) has been 
financing the concept of exposome, supporting studies that have been defined as exposomic 
in nature18. The institute outlined the objective of transforming the exposure science and 
has been identifying the application of the concept of exposome in its studies as a strategy. 
It plans to advance in the characterization of environmental exposure assessment, both 
at individual and population levels, through measurement tools and technologies at 
multiscale. The institute founded the project Hercules (Health and Exposome Research 
Center: Understanding Lifetime Exposures) with headquarters at Emory University (Atlanta, 
USA) and collaboration of universities such as Berkeley and Harvard6,18. 
In Europe, several projects that consider exposomic approaches are in progress. The 
EXPOsOMICS is a research project, led by the Imperial College (London); the HELIX 
(The Human Early-Life Exposome) is mainly allocated in the Instituto de Salud Global de 
Barcelona; and the HEALS (Health and Environment-wide Associations based on Large 
population Surveys) have joint coordination of researchers from France and Greece. These 
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organizations are heavily financed by the European Union and composed by research 
institutes from several countries.
FINAL CONSIDERATIONS
In conclusion, the exposome is an ongoing reality and no longer a promise. The joint use 
of tools of epidemiology, bioinformatics and toxicology can promote the advancement of 
knowledge of the causes of public health outcomes to which the genomic sequencing has 
not clarified completely. Research in the public health area must, increasingly, include such 
tools in their population cohort studies. Succeeding in the characterization of the exposome, 
genetic and environmental determinants will be able to be concomitantly evaluated in the 
same study, in which interactions between gene and environment are examined6,18. Thus, 
the exposome represents a paradigm shift in the concept of making science, leaving the 
binomial unique exposure-outcome for the definitive recognition that health is impacted 
by multiple exposures. With the exposomic methodology available, such recognition can 
be achieved in new study designs12. This proposal will be able to solve the old impasse of 
what is nature (legacy) and of what is nurture (acquired)4. 
We must consider that the concept of exposome is in full adolescence, with 13 years of age, since 
Christopher Wild coined it in 2005. Therefore, for the advancement of exposomic research, which 
integrate multiple scientific areas, there are the challenges of obtaining considerable financing; 
of the integration of knowledge, which determines the work of large research groups; and of the 
analysis of large databases, cross-sectional subject to several areas of knowledge, such as statistics, 
computer science, biomedicine, epidemiology and public health3,12,25. The difficulties in the field 
of bioinformatics are many because variables can be highly correlated and there are always risks 
of spurious correlations12. It is not enough to obtain data and perform correlations. The data 
must become reliable information and the epidemiology has key role in this point. Despite all 
the challenges discussed, the research on exposome is an ongoing reality and must include the 
training of a new body of scientists, who must be conscious of the need of a transdisciplinary 
education12. Such leaders in the area of human exposome must serve as a bridge between the 
multiple fields of research and work in partnerships or teams with scientific capabilities that 
complement each other and, consequently, advance in the answers that science seeks. With 
that, a new generation of researchers is expected, especially biomedical ones, epidemiologists, 
exposure and computing scientists, in addition to innovative and transcontinental research 
programs. The exposome opens a new era for thinking and working the science.
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